Khiron Life Sciences Corp.
Rank 128
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$0.0520
USD
6.67%
Market cap
$5,922,686
Total volume
$34,516
Shares outstanding
113,927,120
Rank 128
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$19,989
|
57.91% |
$0.0520
|
| KHRNF |
Total volume
$14,527
|
42.09% |
Stock price
$0.4213
|
Chart